Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 523

The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.

The Intestinal Microbiome and Estrogen Receptor–Positive Female Breast Cancer

Open access
·2016·JNCI: Journal of the National Cancer Institute

Abstract

The huge communities of residential microbes, including bacteria, viruses, Archaea, and Eukaryotes, that colonize humans are increasingly recognized as playing important roles in health and disease.A complex populous ecosystem, the human gastrointestinal (GI) tract harbors up to 10 11 bacterial cells per gram of luminal content, whose collective genome, the gut metagenome, contains a vastly greater number of individual genes than the human genome.In health, the function of the microbiome might be considered to be in dynamic equilibrium with the host, exerting both local and distant effects.However, 'disequilibrium' may contribute to the emergence of disease, including malignancy.In this review, we discuss how the intestinal bacterial microbiome and in particular how an 'estrobolome,' the aggregate of enteric bacterial genes capable of metabolizing estrogens, might affect women's risk of developing postmenopausal estrogen receptor-positive breast cancer.Estrobolome composition is impacted by factors that modulate its functional activity.Exploring variations in the composition and activities of the estrobolome in healthy individuals and in women with estrogen-driven breast cancer may lead to development of microbiome-based biomarkers and future targeted interventions to attenuate cancer risk.Humans become colonized at birth by microbiota, primarily bacteria (which are the focus of this review) (1,2), and over 90% reside within the gastrointestinal (GI) tract.The GI tract harbors more than 500 different bacterial species, and estimates of the number of bacteria we carry reach 10 11 per gram of luminal content (3-5).Bacterial load, along with species diversity, increases from the stomach to the colon, creating a complex microbial ecosystem (6).The composition of the GI tract microbiota reflects host variables, such as delivery mode, genetics, diet, alcohol intake, environmental exposures, and medications, in particular antibiotics.Investigation of bacterial microbiome composition, function, and assessment of the aggregate of its genes (the metagenome) is now possible via advances in 16S ribosomal RNA (rRNA) sequencing and informatics (7-10).Humans and microbes have coevolved a complex intricate relationship to benefit the host while allowing the intestinal microbiota to thrive in a mutually advantageous equilibrium (11-13).Microbiome perturbation can, however, be associated with risk of developing inflammatory, autoimmune, and malignant disease (14-17).Microbial community dysbiosis, a pathologic disequilibrium, could potentially favor oncogenesis and tumor progression and affect responses to cancer therapy and toxicity profiles of chemotherapeutics (18-20).The human gut microbiome is functional and exerts both local and long-distance effects involving hormonal intermediates, metabolites, and immunologic messengers (21,22).Host-microbe interactions thus have the potential to influence carcinogenesis through mechanisms such as chronic inflammation, induction of genotoxic responses, alteration of the microenvironment, and metabolism (23,24).This could be mediated by the microbial ecosystem as a whole or via specific microbes such as the bacterium Helicobacter pylori, which is associated with increased risk of adenocarcinoma of the stomach in humans (25-27).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jnci/djw029

Cites

156 of 156 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 156 references

Cited by

See all 523

Metadata

Venue
JNCI: Journal of the National Cancer Institute
Published
2016-04-22
Volume
108
Issue
8
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2341191157
Cited by
523
References
156
FWCI
10.98
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Intestinal Microbiome and Estrogen Receptor–Positive Female Breast Cancer. https://app.cochat.ai/papers/10.1093/jnci/djw029
The paper
The Intestinal Microbiome and Estrogen Receptor–Positive Female Breast Cancer. (2016). JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djw029

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.